Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
Unprotected People Reports 
General
Chickenpox (varicella)
Diphtheria
Hepatitis A
Hepatitis B
Hib
HPV
Influenza
Measles
Meningococcal
Mumps
Pertussis
Pneumococcal
Polio
Rabies
Rotavirus
Rubella
Shingles (zoster)
Tetanus
Yellow Fever
Reports by Disease
Reports by Number

Unprotected People Reports: Hepatitis B

Unprotected Babies: Hepatitis B Vaccine at Birth Saves Lives!

Click here for a fully-formatted PDF version of this report
On October 17, 2001, the Advisory Committee on Immunization Practices (ACIP) voted to recommend a birth dose of hepatitis B vaccine for all U. S. infants. (Only for infants of mothers whose HBsAg test is assured to be negative does ACIP now approve giving the first dose as late as two months of age.)
The following article is adapted from an open letter by Deborah L. Wexler, M.D., to ACIP, American Academy of Pediatrics, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, National Medical Association, and other medical professional organizations.
The Immunization Action Coalition (IAC) urges all health professionals and hospitals to protect all infants from hepatitis B virus (HBV) infection by administering the first dose of hepatitis B vaccine to every infant at birth and no later than hospital discharge.

Approximately 19,000 women with chronic hepatitis B infection give birth in the United States each year. Ninety percent of perinatal infections can be prevented by postexposure prophylaxis given within 12 hours of birth. Tragically, many babies are exposed to HBV at birth but do not receive appropriate postexposure prophylaxis.

Because thimerosal has been removed from all pediatric hepatitis B vaccines in the United States, concerns about thimerosal should no longer be an obstacle for practitioners in enacting a universal birth dose policy.

Why is such a policy necessary? Following are some of the ways infants who are not vaccinated at birth become infected:
  • The pregnant woman is tested and found to be hepatitis B surface antigen (HBsAg) positive, but her status is not communicated to the newborn nursery. The infant receives neither hepatitis B vaccine nor HBIG protection at birth.
        
  • A chronically infected pregnant woman is tested but with the wrong test, HBsAb (antibody to hepatitis B surface antigen), instead of HBsAg. This is a common mistake since these two test abbreviations differ by only one letter. Her incorrectly ordered test result is "negative," so her doctor believes her infant does not need postexposure prophylaxis.
          
  • The pregnant woman is HBsAg positive, but her test results are misinterpreted or mistranscribed into her prenatal record or her infant's chart. Her infant does not receive HBIG or hepatitis B vaccine.
           
  • The pregnant woman is not tested for HBsAg either prenatally or in the hospital at the time of delivery. Her infant does not receive hepatitis B vaccine in the hospital, even though it is recommended within 12 hours of birth for infants whose mothers' test results are unknown.
          
  • The woman is tested in early pregnancy for HBsAg and is found to be negative. She develops HBV infection later in pregnancy, but it is not detected, even though it is recommended by CDC that high-risk women be retested later in pregnancy. Because the infection is not clinically detected by her health care provider, her infant does not receive hepatitis B vaccine or HBIG at birth.
          
  • The mother is HBsAg negative, but the infant is exposed to HBV postnatally from another family member or caregiver. This occurs in two-thirds of the cases of childhood transmission.
While there are advantages to giving the first dose at a later well-baby visit, these are advantages of administrative convenience. The primary advantage of giving the first dose at birth is that it saves lives.

IAC recently asked hepatitis coordinators at every state health department as well as at city and county CDC projects to express their views about providing hepatitis B vaccine in the hospital. Their responses contained many examples of children who were unprotected or inadequately protected due to health professionals not ordering, misordering, misinterpreting, mistranscribing, and miscommunicating the hepatitis B test results of the children's mothers.

These state coordinators' reports tell us that no matter how well health care providers think they are doing with HBsAg screening of all pregnant women, serious mistakes continue to occur; children are unnecessarily being exposed without the benefit of postexposure prophylaxis, and at least one baby has died. In order to overcome these failures, all 50 states overwhelmingly endorse providing a birth dose.

We must vaccinate every baby in the hospital prior to discharge regardless of the HBsAg status of the mother. For those providers who choose to use hepatitis B-containing combination vaccine, i.e., Comvax, they may do so. However, since this vaccine cannot be given at birth, monovalent hepatitis B vaccine must be given at birth and then the hepatitis B vaccine series can be completed with three doses of the combination vaccine. (Giving four doses of hepatitis B vaccine has been shown to be safe in several clinical studies.)

Hepatitis B vaccine is one of the most effective vaccines available. Studies have shown that infants of the most highly infectious mothers (women who are both HBsAg and HBeAg positive) who receive postexposure prophylaxis with hepatitis B vaccine alone (without HBIG) at birth are protected in 90–95% of cases, essentially the same level of protection afforded by administering hepatitis B vaccine in addition to HBIG. Even higher rates of protection with postexposure prophylaxis have been demonstrated in infants born to less infectious mothers (those who are HBsAg positive and HBeAg negative).

Please read the hepatitis coordinators survey results (see the web address in the box below), including descriptions of their experiences with failures of the current system—failures that can be largely prevented by administering hepatitis B vaccine to infants before they go home from the hospital.

Your support for providing a birth dose of hepatitis B vaccine to infants while still in the hospital will protect and save lives that are now being put at risk.
 
Here's more information about why to give the birth dose
To read the results of IAC's survey of state health department hepatitis coordinators, visit: www.immunize.org/birthdose/survey.htm For more information about why all babies should receive the first dose of hepatitis B vaccine in the hospital, go to the Birth Dose page of IAC's website at: www.immunize.org/birthdose

 
10/7/02 • REPORT #45
Disclaimer: The Immunization Action Coalition (IAC) publishes Unprotected People Reports for the purpose of making them available for our readers' review. We have not verified the content of this report.
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.